Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Peripheral T-cell lymphoma: what's the role for transplant?

Cohen JB, Flowers CR.

Oncology (Williston Park). 2013 Sep;27(9):891-2. No abstract available.

2.

Peripheral T-cell lymphoma: time for a T-cell-centric standard of care.

Saint Fleur-Lominy S, Diefenbach CS.

Oncology (Williston Park). 2013 Sep;27(9):885-6. No abstract available.

3.

Peripheral T-cell lymphoma: new therapeutic strategies.

Petrich AM, Rosen ST.

Oncology (Williston Park). 2013 Sep;27(9):878-84. Review.

4.

Combination chemotherapy followed by autologous stem cell transplant for enteropathy-associated T-cell lymphoma.

Lennard A.

Br J Haematol. 2007 Apr;137(2):170; author reply 171. No abstract available.

PMID:
17391498
5.

Update: peripheral T-cell lymphomas.

Savage KJ.

Curr Hematol Malig Rep. 2011 Dec;6(4):222-30. doi: 10.1007/s11899-011-0100-3. Review.

PMID:
21953415
6.

High-dose chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: complete response at transplant predicts survival.

Kim MK, Kim S, Lee SS, Sym SJ, Lee DH, Jang S, Park CJ, Chi HS, Huh J, Suh C.

Ann Hematol. 2007 Jun;86(6):435-42. Epub 2007 Jan 26.

PMID:
17256144
7.

High-dose therapy and stem cell transplantation.

Zinzani PL.

Semin Hematol. 2010 Apr;47 Suppl 1:S15-7. doi: 10.1053/j.seminhematol.2010.01.017. Review.

PMID:
20359581
8.

Prolonged survival of patients with peripheral T-cell lymphoma after first-line intensive sequential chemotherapy with autologous stem cell transplantation.

Prochazka V, Faber E, Raida L, Vondrakova J, Kucerova L, Jarosova M, Indrak K, Papajik T.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2009 Mar;153(1):63-6.

9.

[Diagnosis and treatment of peripheral T-cell lymphoma].

Suzumiya J, Moriyama I, Kawakami K.

Nihon Rinsho. 2012 Apr;70 Suppl 2:519-24. Japanese. No abstract available.

PMID:
23134009
10.

Long-term outcomes of autologous stem cell transplantation for peripheral T-cell lymphomas across the Thames Valley (1997-2012).

Sims MC, Newell K, Eyre TA, Hatton C, Collins GP.

Br J Haematol. 2015 May;169(3):452-5. doi: 10.1111/bjh.13226. Epub 2014 Nov 16. No abstract available.

PMID:
25399667
11.

Prognostic factors and clinical outcomes of high-dose chemotherapy followed by autologous stem cell transplantation in patients with peripheral T cell lymphoma, unspecified: complete remission at transplantation and the prognostic index of peripheral T cell lymphoma are the major factors predictive of outcome.

Yang DH, Kim WS, Kim SJ, Bae SH, Kim SH, Kim IH, Yoon SS, Mun YC, Shin HJ, Chae YS, Kwak JY, Kim H, Kim MK, Kim JS, Won JH, Lee JJ, Suh CW.

Biol Blood Marrow Transplant. 2009 Jan;15(1):118-25. doi: 10.1016/j.bbmt.2008.11.010.

12.

Current and novel treatment options for peripheral T-cell lymphoma.

Horwitz SM.

Clin Adv Hematol Oncol. 2015 Jul;13(7):463-6. No abstract available.

PMID:
26353042
13.

Enhancing existing approaches to peripheral T-cell lymphoma.

Foss FM.

Semin Hematol. 2010 Apr;47 Suppl 1:S8-10. doi: 10.1053/j.seminhematol.2010.01.012. Review.

PMID:
20359584
14.

Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01.

d'Amore F, Relander T, Lauritzsen GF, Jantunen E, Hagberg H, Anderson H, Holte H, Österborg A, Merup M, Brown P, Kuittinen O, Erlanson M, Østenstad B, Fagerli UM, Gadeberg OV, Sundström C, Delabie J, Ralfkiaer E, Vornanen M, Toldbod HE.

J Clin Oncol. 2012 Sep 1;30(25):3093-9. doi: 10.1200/JCO.2011.40.2719. Epub 2012 Jul 30.

PMID:
22851556
15.

[Development of novel therapeutic agents for adult T-cell leukemia-lymphoma].

Tobinai K.

Rinsho Ketsueki. 2012 Oct;53(10):1665-74. Review. Japanese. No abstract available.

PMID:
23037739
16.

Long-term remission in a patient with hepatosplenic gammadelta T cell lymphoma treated with bortezomib and high-dose CHOP-like chemotherapy followed by autologous peripheral stem cell transplantation.

Otrock ZK, Hatoum HA, Salem ZM, Tawil A, Mahfouz RA, Zaatari GS, Bazarbachi A.

Ann Hematol. 2008 Dec;87(12):1023-4. doi: 10.1007/s00277-008-0523-7. Epub 2008 Jun 28. No abstract available.

PMID:
18587577
17.

Peripheral T-cell lymphoma: a case-based discussion of recent advances in patient management.

Franco CM, Popplewell LL, Horwitz SM.

Clin Adv Hematol Oncol. 2011 Apr;9(4 Suppl 9):1-16. Review.

PMID:
21559001
18.

Current and future aggressive peripheral T-cell lymphoma treatment paradigms, biological features and therapeutic molecular targets.

Rodríguez J, Gutiérrez A, Martínez-Delgado B, Perez-Manga G.

Crit Rev Oncol Hematol. 2009 Sep;71(3):181-98. doi: 10.1016/j.critrevonc.2008.10.011. Epub 2008 Dec 3. Review.

PMID:
19056295
19.

Analysis of prognostic factors in peripheral T-cell lymphoma: prognostic value of serum albumin and mediastinal lymphadenopathy.

Chihara D, Oki Y, Ine S, Yamamoto K, Kato H, Taji H, Kagami Y, Yatabe Y, Nakamura S, Morishima Y.

Leuk Lymphoma. 2009 Dec;50(12):1999-2004. doi: 10.3109/10428190903318311.

PMID:
19860627
20.

Current treatment of peripheral T-cell lymphoma.

Horwitz SM, Coiffier B, Hsi ED, Pro B.

Clin Adv Hematol Oncol. 2011 Aug;9(8 Suppl 16):1-15. Review.

PMID:
22361915

Supplemental Content

Support Center